Jae H. Park, MD | Authors


Examining the Current Role of CAR T-Cell Therapy in Acute Myeloid Leukemia

June 07, 2019

Jae H. Park, MD, discusses the current role and challenges in using CAR T-cell therapy in patients with relapsed or refractory acute myeloid leukemia. The 2 challenges now in this area are target selection and patient selection.